gBETA Medtech Announces Spring 2021 Companies
Summary
The program is designed to help startups gain early customer traction on their product or idea, and establish metrics that can make them competitive applicants for full-time, equity-based accelerators or seed investment. “Our partnership with gBETA Medtech and University Enterprise Laboratories (UEL) recognizes and stimulates innovation not only in Minnesota, but also the entire region,” said DRIVe Project Officer David Winter. gBETA Medtech’s founding sponsor is Boston Scientific and the cohort receives mentorship support from Mayo Clinic, University of Minnesota and Medical Alley Association. Rhaeos has raised $2.3M in financing, received FDA breakthrough designation, published clinical data in Science and Nature family journals, and is on track for initial market entry in Q1 2022. OpalGenix has recruited an accomplished startup CEO, completed pediatric clinical studies, obtained USPTO and European patent claims, and received notice of intent to fund an NIH STTR grant proposal.
Classifications
AskAI Classifications
LabelsLinked Companies
